Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuronavigation-assisted Stereotactic Minimally Invasive Puncture Combined With Tenecteplase for the Treatment of Acute Spontaneous Lobar Intracerebral Hemorrhage(NALICE-TNK)： a Randomized, Outcome-blinded, Multi-center Trial

NCT07471256 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.

NCT NCT07471256
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07471256 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuronavigation-assisted Stereotactic Minimally Invasive Puncture Combined With Tenecteplase for the Treatment of Acute Spontaneous Lobar Intracerebral Hemorrhage(NALICE-TNK)： a Randomized, Outcome-blinded, Multi-center Trial
Lead sponsor
Beijing Tiantan Hospital
Phase
Phase 3
Overall status
Not yet recruiting
Start date
March 31, 2026
Completion date
December 31, 2028
Enrollment
636 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intracerebral hemorrhage lobar